Morten Munk FUJIFILM Diosynth Biotechnologies

Morten Munk’s career is comprised of more than 35 years of experience within the global biopharmaceutical industry. One common denominator for his approach is to have a holistic and broad perspective on all aspects and steps in the production of biopharmaceuticals. He believes; collaboration, knowledge sharing, and optimal use of all relevant technologies are the key factors in ensuring the availability of the best product for the patient. Morten joined Fujifilmin in 2020 where holds a role as Director, Global Alliance Management. In 2001 he was one of the co-founders of CMC Biologics (now AGC Biologics) after he had been working 14 years at Novo Nordisk. Furthermore, Morten has authored or contributed to several technical articles and guidelines. He is frequently invited to give scientific and technical presentations at international conferences. Additionally, he is active in the biopharmaceutical community as a member of scientific committees for various international conferences as well as a volunteer in international industry organizations, where the most important naturally is PDA, but also ISPE and BPOG.